Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 1/2018

07.06.2017 | Original Article

Serum oxidized LDL and the factors associated with LDL oxidation in black South African type 2 diabetes mellitus patients

verfasst von: Jim Thytharayil Joseph, Farzana Ganjifrockwala, Grace George

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Diabetes is a metabolic disorder that is increasing in prevalence at a very fast pace in developing countries such as South Africa. There is a strong link between diabetes and cardiovascular disease with studies showing that diabetic patients are two to four times more likely to suffer from cardiovascular disease than healthy people. The dysregulation of lipid and lipoprotein metabolism and the subsequent oxidation of low-density lipoprotein (LDL) is one of the major reasons for the increased cardiovascular risk associated with diabetes. The main objective of this study was to analyze the concentrations of oxidized LDL in diabetic patients and to uncover factors associated with oxidized LDL. In total, 67 type 2 diabetic mellitus patients and 48 healthy control participants participated in the cross-sectional study. Oxidized LDL concentration in serum and the total antioxidant status were determined by ELISA, while the size of LDL and high-density lipoprotein (HDL) particles were determined by gradient gel electrophoresis. The concentration of oxidized LDL was significantly elevated in the diabetic patients. The diabetic patients also had a significantly higher percentage of small dense LDL and a higher concentration of triglycerides than the control group, while their peak LDL size and the total antioxidant capacity were significantly lower than those in the control group. The percentage of small dense LDL, triglycerides, peak LDL size, and total antioxidant capacity also varied significantly across the quartiles of oxidized LDL in the entire study population. Multiple regression analysis revealed that triglyceride and glycated hemoglobin were the most important parameters to be independently associated with oxidized LDL concentrations. The diabetic patients had high concentrations of small dense LDL and oxidized LDL. The concentrations of the highly atherogenic oxidized LDL particles were found to be independently associated with the concentrations of triglycerides and glycated hemoglobin. This indicated that proper diabetic control could reduce the risk of cardiovascular disease in these individuals.
Literatur
1.
Zurück zum Zitat Shaw JE, Sicree RA, Zimmet PZ. Global estimates for the prevalence of diabetes 2010 and 2030. Diabetes Res Clin Pr. 2010;87(1):4–14.CrossRef Shaw JE, Sicree RA, Zimmet PZ. Global estimates for the prevalence of diabetes 2010 and 2030. Diabetes Res Clin Pr. 2010;87(1):4–14.CrossRef
2.
Zurück zum Zitat Peer N, Steyn K, Lombard C, Vythilingum B, Levitt NS. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS One. 2012;7(9):e43336.CrossRefPubMedPubMedCentral Peer N, Steyn K, Lombard C, Vythilingum B, Levitt NS. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS One. 2012;7(9):e43336.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Nakhjavani M, Khajeali L, Esteghamati A, Morteza A, Jamali A, Dadkhahipour S. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids. 2010;45(4):321–7.CrossRefPubMed Nakhjavani M, Khajeali L, Esteghamati A, Morteza A, Jamali A, Dadkhahipour S. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids. 2010;45(4):321–7.CrossRefPubMed
5.
Zurück zum Zitat Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272(34):20963–6.CrossRefPubMed Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272(34):20963–6.CrossRefPubMed
7.
Zurück zum Zitat Ionica F, Popescu F, Pisoschi C, Gofita E. Clinical consequence of the physicochemical properties of LDL particles in type 2 diabetes. Curr Health Sci J. 2009;35(1):73–8. Ionica F, Popescu F, Pisoschi C, Gofita E. Clinical consequence of the physicochemical properties of LDL particles in type 2 diabetes. Curr Health Sci J. 2009;35(1):73–8.
8.
Zurück zum Zitat Yoshida H, Kisugi R. Mechanism of LDL oxidation. Clinica Chemica Acta. 2010;411(23–24):1875–82.CrossRef Yoshida H, Kisugi R. Mechanism of LDL oxidation. Clinica Chemica Acta. 2010;411(23–24):1875–82.CrossRef
9.
Zurück zum Zitat Li D, Mehta JL. Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res. 2005;68(3):353–4.CrossRefPubMed Li D, Mehta JL. Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res. 2005;68(3):353–4.CrossRefPubMed
10.
Zurück zum Zitat Singh AT, Rainwater DL, Haffner SM, Vande Berg JL, Shelledy WR, Moore PH, Moore PH Jr, Dyer TD. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol. 1995;15(11):1805–11.CrossRefPubMed Singh AT, Rainwater DL, Haffner SM, Vande Berg JL, Shelledy WR, Moore PH, Moore PH Jr, Dyer TD. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol. 1995;15(11):1805–11.CrossRefPubMed
11.
Zurück zum Zitat Vasquez G, Duva S, Jacobs RD Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29:115–28.CrossRef Vasquez G, Duva S, Jacobs RD Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29:115–28.CrossRef
12.
Zurück zum Zitat Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus: a prospective cohort study of men in the normative aging study. Am J Epidemiol. 1992;136(12):1474–86.CrossRefPubMed Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus: a prospective cohort study of men in the normative aging study. Am J Epidemiol. 1992;136(12):1474–86.CrossRefPubMed
13.
Zurück zum Zitat Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr. 2007;61(12):1373–9.CrossRefPubMed Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr. 2007;61(12):1373–9.CrossRefPubMed
14.
Zurück zum Zitat Srikanthan P, Seeman TE, Karlamangla AS. Waist-hip-ratio as a predictor of all-cause mortality in high-functioning older adults. Ann Epidemiol. 2009;19:724–31.CrossRefPubMedPubMedCentral Srikanthan P, Seeman TE, Karlamangla AS. Waist-hip-ratio as a predictor of all-cause mortality in high-functioning older adults. Ann Epidemiol. 2009;19:724–31.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:150–9.CrossRef Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:150–9.CrossRef
16.
Zurück zum Zitat Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Vergès B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Investig. 2000;30:685–94. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Vergès B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Investig. 2000;30:685–94.
17.
Zurück zum Zitat Karimian NP, Adeli K. Insulin silences apolipoprotein B mRNA translation by inducing intracellular traffic into cytoplasmic RNA granules. Biochemistry. 2011;50(32):6942–50.CrossRef Karimian NP, Adeli K. Insulin silences apolipoprotein B mRNA translation by inducing intracellular traffic into cytoplasmic RNA granules. Biochemistry. 2011;50(32):6942–50.CrossRef
18.
Zurück zum Zitat Yanai H, Hirowatari Y, Ito K, Kurosawa H, Tada N, Yoshida H. Understanding of diabetic dyslipidemia by using tJ Clin Med Reshe anion-exchange high performance liquid chromatography data. 2016;8(5):424–426. Yanai H, Hirowatari Y, Ito K, Kurosawa H, Tada N, Yoshida H. Understanding of diabetic dyslipidemia by using tJ Clin Med Reshe anion-exchange high performance liquid chromatography data. 2016;8(5):424–426.
19.
Zurück zum Zitat Au WS, Kung HF, Lin MC. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells. Diabetes. 2003;52(5):1073–80.CrossRefPubMed Au WS, Kung HF, Lin MC. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells. Diabetes. 2003;52(5):1073–80.CrossRefPubMed
20.
Zurück zum Zitat Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Breslow JL. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest. 1993;92(3):1143–52.CrossRefPubMedPubMedCentral Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Breslow JL. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest. 1993;92(3):1143–52.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Rammadan SS, Cevik C, Quobaili FA. Impact of type 2 diabetes on serum CETP levels. IJPSRR. 2014;26, 1,15:98–100. Rammadan SS, Cevik C, Quobaili FA. Impact of type 2 diabetes on serum CETP levels. IJPSRR. 2014;26, 1,15:98–100.
22.
Zurück zum Zitat Kiranmayi PV, Vivekanand N. Pandit Vl. The study of lipid profile and oxidised-LDL in type 2 diabetes mellitus. SJAMS. 2014;2(3D):1119–22. Kiranmayi PV, Vivekanand N. Pandit Vl. The study of lipid profile and oxidised-LDL in type 2 diabetes mellitus. SJAMS. 2014;2(3D):1119–22.
23.
Zurück zum Zitat Superko RH. Advanced lipoprotein testing and subfraction are clinically useful. Circulation. 2009;119:2383–95.CrossRefPubMed Superko RH. Advanced lipoprotein testing and subfraction are clinically useful. Circulation. 2009;119:2383–95.CrossRefPubMed
24.
Zurück zum Zitat Adiels M, Olofson SO, Taskinen MR, Boren J. Overproduction of very low-density ipoproteins is the hallmark of the dyslipidemia in metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:629–36.CrossRef Adiels M, Olofson SO, Taskinen MR, Boren J. Overproduction of very low-density ipoproteins is the hallmark of the dyslipidemia in metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:629–36.CrossRef
25.
Zurück zum Zitat EEMN E, Almarzouki A, Assiri AM, Omebea M, Babakr AT. Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance in Saudi men. Diabetol Metab Syndr. 2014;6:94.CrossRef EEMN E, Almarzouki A, Assiri AM, Omebea M, Babakr AT. Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance in Saudi men. Diabetol Metab Syndr. 2014;6:94.CrossRef
26.
Zurück zum Zitat Wang J, Gu Q, Li K, Zhang C. CETP and oxidized LDL levels increase in dyslipidemic subjects. Clin Biochem. 2007;40:995–9.CrossRefPubMed Wang J, Gu Q, Li K, Zhang C. CETP and oxidized LDL levels increase in dyslipidemic subjects. Clin Biochem. 2007;40:995–9.CrossRefPubMed
27.
Zurück zum Zitat Sobal G, Menzel J, Sinzinger H. Why is glycated LDL more susceptible to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids. 2000;63(4):177–86.CrossRefPubMed Sobal G, Menzel J, Sinzinger H. Why is glycated LDL more susceptible to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids. 2000;63(4):177–86.CrossRefPubMed
28.
Zurück zum Zitat Opara EC, Rahman EA, Soliman S, Kamel WA, Souka S, Lowe JE, Aleem SA. Depletion of total antioxidants in type 2 diabetes. Metabolism. 1999;48(11):1414–7.CrossRefPubMed Opara EC, Rahman EA, Soliman S, Kamel WA, Souka S, Lowe JE, Aleem SA. Depletion of total antioxidants in type 2 diabetes. Metabolism. 1999;48(11):1414–7.CrossRefPubMed
29.
Zurück zum Zitat Ceriello A, Bortolotti N, Pirisi M, Crescentitni A, Tonutti L, Motz E, Russo A, Glaomello R, Stel G, Taboga C. Total antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care. 1997;20(10):1589–93.CrossRefPubMed Ceriello A, Bortolotti N, Pirisi M, Crescentitni A, Tonutti L, Motz E, Russo A, Glaomello R, Stel G, Taboga C. Total antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care. 1997;20(10):1589–93.CrossRefPubMed
30.
Zurück zum Zitat Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothromobosis. FASEB J. 2001;15(12):2073–84.CrossRefPubMed Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothromobosis. FASEB J. 2001;15(12):2073–84.CrossRefPubMed
32.
Zurück zum Zitat Dhanunjaya Y, Vijaya D, Dolia PB. Decreased basal activity of HDL associated enzyme: paraoxonase (PON) during uncompensated oxidative stress among type 2 diabetes mellitus patients. Int J Diabetes Dev Ctries. 2015;35(3):483–290.CrossRef Dhanunjaya Y, Vijaya D, Dolia PB. Decreased basal activity of HDL associated enzyme: paraoxonase (PON) during uncompensated oxidative stress among type 2 diabetes mellitus patients. Int J Diabetes Dev Ctries. 2015;35(3):483–290.CrossRef
Metadaten
Titel
Serum oxidized LDL and the factors associated with LDL oxidation in black South African type 2 diabetes mellitus patients
verfasst von
Jim Thytharayil Joseph
Farzana Ganjifrockwala
Grace George
Publikationsdatum
07.06.2017
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 1/2018
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-017-0559-0

Weitere Artikel der Ausgabe 1/2018

International Journal of Diabetes in Developing Countries 1/2018 Zur Ausgabe